Company record · updated October 7, 2026
Prognomiq Inc Cl A: 8 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs September 30, 2025 to June 30, 2026.
8observations
8source filings
8verified rows
2026-06-30most recent as-of date
Source rails for this company: N-PORT fund mark (8).
Reported by 2 filers: T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-06-30 | price per share | 0.15 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 90997.05 / balance 606647.0 [pp] | 000109926326009596 |
| 2026-06-30 | price per share | 0.15 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 4100.7 / balance 27338.0 [pp] | 000109926326009591 |
| 2026-03-31 | price per share | 0.15 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 4100.7 / balance 27338.0 [pp] | 000109926326006593 |
| 2026-03-31 | price per share | 0.15 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 90997.05 / balance 606647.0 [pp] | 000109926326006598 |
| 2025-12-31 | price per share | 0.15 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 4100.7 / balance 27338.0 [pp] | 000109926326002544 |
| 2025-12-31 | price per share | 0.15 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 90997.05 / balance 606647.0 [pp] | 000109926326002549 |
| 2025-09-30 | price per share | 0.15 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 90997.05 / balance 606647.0 [pp] | 000109926325003642 |
| 2025-09-30 | price per share | 0.15 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 4100.7 / balance 27338.0 [pp] | 000109926325003637 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.